PhRMA in partnership with the ALS Association has released a 2016 summary report of medicines in development for rare diseases. This informative overview provides an excellent snapshot of the progress being made in specialty drug development and features a link to all of the drugs in the pipeline by disease and manufacturer.
by Jonathan D. Katz